Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

15.4%

10 terminated out of 65 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

6%

4 trials in Phase 3/4

Results Transparency

40%

10 of 25 completed with results

Key Signals

10 with results71% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (19)
Early P 1 (1)
P 1 (15)
P 2 (10)
P 3 (1)
P 4 (3)

Trial Status

Completed25
Unknown14
Terminated10
Recruiting8
Active Not Recruiting5
Not Yet Recruiting2

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (65)

Showing 20 of 20 trials
NCT04128332Not ApplicableCompletedPrimary

Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

NCT03536793RecruitingPrimary

Tumour Regulatory Molecules in Early Pancreatic Cancer Detection

NCT04258813Not ApplicableActive Not Recruiting

Onco-primary Care Networking to Support TEAM-based Care

NCT03977233Phase 2Recruiting

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

NCT05252390Phase 1Terminated

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT05485974Phase 1Active Not Recruiting

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

NCT05163028Phase 1Active Not Recruiting

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

NCT02905578Phase 2Completed

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

NCT06046794Not ApplicableRecruitingPrimary

Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients

NCT06344507Recruiting

Iconographic Registry of Pancreatobiliary Endoscopy Procedures

NCT06940778Active Not Recruiting

LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

NCT05041335Not ApplicableNot Yet RecruitingPrimary

Wet Heparinized Suction for Abdominal Cancer

NCT03822936Phase 2TerminatedPrimary

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

NCT04028479Completed

The Registry of Oncology Outcomes Associated with Testing and Treatment

NCT06148298RecruitingPrimary

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

NCT05830097Phase 1Unknown

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

NCT05470166Not ApplicableCompleted

Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

NCT03133286Completed

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

NCT05496777Not ApplicableCompleted

Home-based Prehabilitation in Pancreatic Resection

Scroll to load more

Research Network

Activity Timeline